ABOUT TARGETED GENETICS CORPORATION

Targeted Genetics Corporation is a biotechnology company committed to the development and commercialization of innovative therapies for the prevention and treatment of diseases with significant unmet medical need. Targeted Genetics is based in Seattle, Washington and has been public since May 1994 and its stock trades on the NASDAQ Capital Market under the ticker symbol TGEN.